News

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...
Delaware's highest court ruled on Thursday that patients suing drugmakers GSK, Pfizer, Sanofi and Boehringer Ingelheim cannot ...
Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...
Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung juries.
Boehringer Ingelheim, GSK, Pfizer and Sanofi , opens new tab all sold brand name Zantac at various times since it was approved in 1983, and have been named in tens of thousands of lawsuits over ...
An attorney for plaintiff Angela Valadez argued for a direct link between her cancer diagnosis and Zantac, ... 89, is suing two pharmaceutical companies, GSK and Boehringer Ingelheim, that once ...
A Boehringer Ingelheim executive testified refrigeration was never required in any stage of production, transport or sale. Zantac exec testifies on claims heat degraded heartburn drug into ...
The jury in Cook County, Ill. circuit court agreed with arguments from drugmakers GSK and Boehringer Ingelheim that the plaintiff, 89-year-old Illinois resident Angela Valadez, had not proven her ...
In first Zantac trial, GSK and Boehringer Ingelheim gain key victory By Kevin Dunleavy May 23, 2024 4:10pm GSK Boehringer Ingelheim Zantac litigation ...
SAN FRANCISCO (MarketWatch) -- Boehringer Ingelheim Pharmaceuticals Inc. after Thursday's bell said it has agreed with Johnson & Johnson Boehringer Ingelheim buys U.S. Zantac rights Share ...